Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ariane K. Kawata, William R. Lenderking, Olabimpe R. Eseyin, David Kerstein, Joice Huang, Hui Huang, Pingkuan Zhang & Huamao M. Lin. (2019) Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study. Journal of Medical Economics 22:9, pages 924-935.
Read now
Read now
Hosein Ameri, Mahmood Yousefi, Mehdi Yaseri, Azin Nahvijou, Mohammad Arab & Ali Akbari Sari. (2019) Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients. Expert Review of Pharmacoeconomics & Outcomes Research 19:1, pages 89-96.
Read now
Read now
Daniel SJ Costa, Neil K Aaronson, Peter M Fayers, Peter S Grimison, Monika Janda, Julie F Pallant, Donna Rowen, Galina Velikova, Rosalie Viney, Tracey A Young & Madeleine T King. (2014) Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer’s Quality of Life Questionnaire C30: a confirmatory versus exploratory approach. Patient Related Outcome Measures 5, pages 119-129.
Read now
Read now
Ralph Crott. (2014) Mapping algorithms from QLQ-C30 to EQ-5D utilities: no firm ground to stand on yet. Expert Review of Pharmacoeconomics & Outcomes Research 14:4, pages 569-576.
Read now
Read now
Articles from other publishers (19)
Madeleine T. King, D. A. Revicki, R. Norman, F. Müller, R.C. Viney, A. S. Pickard, D. Cella, J. W. Shaw, Neil Aaronson, John Brazier, David Cella, Daniel Costa, Peter Fayers, Peter Grimison, Monika Janda, Georg Kemmler, Madeleine T. King, Nan Luo, Helen McTaggart-Cowan, Rebecca Mercieca-Bebber, Richard Norman, Dennis Revicki, Stuart Peacock, Simon Pickard, Donna Rowen, Galina Velikova, Rosalie Viney, Deborah Street, Tracey Young & Margaret-Ann Tait. (2023) United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument. PharmacoEconomics - Open.
Crossref
Crossref
Colman B. Taylor, Kelly J. Thompson, Carol HodgsonPhDPhD, Cheelim LiewMPHMPH, Edward Litton, Forbes McGain, Alistair NicholPhDPhD, Rashmi RauniyarMPHMPH, Emma RidleyPhDPhD & Alisa HigginsPhDPhD. (2023) Economic evaluations for intensive care unit randomised clinical trials in Australia and New Zealand: Practical recommendations for researchers. Australian Critical Care 36:3, pages 431-437.
Crossref
Crossref
Helen McTaggart-Cowan, Madeleine T. King, Richard Norman, Daniel S. J. Costa, A. Simon Pickard, Rosalie Viney, Stuart J. Peacock, Kelvin Chan, Jeffery Hoch, Natasha Leighl, Nicole Mittmann & Dean Regier. (2022) The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study. Health and Quality of Life Outcomes 20:1.
Crossref
Crossref
Norma B. Bulamu, Ravi Vissapragada, Gang Chen, Julie Ratcliffe, Louise A. Mudge, B. Mark Smithers, Elizabeth A. Isenring, Lorelle Smith, Glyn G. Jamieson, David I. Watson, Louise A. Mudge, Justin Bessell, Andrew Barbour, Elizabeth A. Isenring, Ahmad Aly, Stephen Archer, Mohammed Ballal, Jessica Barbon, Katie Benton, Melissa Bond, Melissa Berryman, Tim Bright, Richard Cade, Anna Cardamis, Rosemary Carroll, Kara Cashman, Larissa Chan, Brooke Chapman, Sally Chapman, Derek Chen, Jacob Chisholm, Wendy Davidson, Peter Devitt, Cuong Dong, Ra’eesa Doola, Suzanne Edwards, Krishna Epari, Maree Farley, Julie Farrow, Maree Ferguson, David Fletcher, Kerry Forbes, Katherine Fullerton, Philip Game, Susan Gan, David Gotley, Belinda Gout, Jodi Gray, Susan Heaney, Glyn G. Jamieson, Mary Anne Johnson, Megan Johnstone, Sanjeeva Kariyawasam, Jonathan Karnon, Amber Kelaart, Liz Kellett, Erin Kennedy, Rhiannon Krane, Sylvia Lemass, Jenelle Loeliger, Andrew Lord, John Ludbrook, Catherine McFarlane, Michelle McPhee, Selena Yue-Xian Ooi, Leonie Pearce, Kate Pettigrew, Emma Putrus, Georgina Rassias, Alison Shanks, Jon Shenfine, Emma Louise Smith, Lorelle Smith, Justin Singleton, B. Mark Smithers, Rebecca Lindstrom-Sowman, John Spillane, Liliana Sputore, Belinda Steer, Tom Sullivan, Laisa Teleni, Deb Tolcher, Janine Thomas, Sarah Thompson, Tina Thorpe, David I. Watson, Cheryl Watterson, Vanessa Wills, Anita Wilton, Kellie Wright & Tim Wright. (2021) Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy. Health and Quality of Life Outcomes 19:1.
Crossref
Crossref
Aureliano Paolo Finch, Eva Gamper, Richard Norman, Rosalie Viney, Bernhard Holzner, Madeleine King & Georg Kemmler. (2021) Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment. PharmacoEconomics 39:9, pages 1085-1098.
Crossref
Crossref
Madeleine T. King, Richard Norman, Rebecca Mercieca-Bebber, Daniel S.J. Costa, Helen McTaggart-Cowan, Stuart Peacock, Monika Janda, Fabiola Müller, Rosalie Viney, Alan Simon Pickard, David Cella, N. Aaronson, J. Brazier, D. Cella, D.S.J. Costa, P. Fayers, P. Grimison, M. Janda, G. Kemmler, M.T. King, H. McTaggart-Cowan, R. Mercieca-Bebber, R. Norman, S. Peacock, A.S. Pickard, D. Rowen, G. Velikova, R. Viney, D. Street & T. Young. (2021) The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set. Value in Health 24:6, pages 862-873.
Crossref
Crossref
Dennis A. Revicki, Madeleine T. King, Rosalie Viney, A. Simon Pickard, Rebecca Mercieca-Bebber, James W. Shaw, Fabiola Müller & Richard Norman. (2021) United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument. Medical Decision Making 41:4, pages 485-501.
Crossref
Crossref
Mahmood Yousefi, Azin Nahvijou, Ali Akbari Sari & Hosein Ameri. (2021) Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country. Value in Health Regional Issues 24, pages 57-66.
Crossref
Crossref
Azin Nahvijou, Hossein Safari, Mahmood Yousefi, Marziyeh Rajabi, Morteza Arab-Zozani & Hosein Ameri. (2020) Mapping the cancer-specific FACT-B onto the generic SF-6Dv2. Breast Cancer 28:1, pages 130-136.
Crossref
Crossref
Richard Huan Xu, Eliza Lai Yi Wong, Jun Jin, Ying Dou & Dong Dong. (2020) Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas. The European Journal of Health Economics 21:9, pages 1363-1373.
Crossref
Crossref
Michael Schlander. (2020) PRO („patient-reported outcomes“) und Lebensqualität in der OnkologiePatient-reported outcomes (PRO) and quality of life in oncology. Forum 35:5, pages 382-390.
Crossref
Crossref
Ann-Jean C. C. Beck, Jacobien M. Kieffer, Valesca P. Retèl, Lydia F. J. van Overveld, Robert P. Takes, Michiel W. M. van den Brekel, Wim H. van Harten & Martijn M. Stuiver. (2019) Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?. PLOS ONE 14:12, pages e0226077.
Crossref
Crossref
Helen McTaggart-Cowan, Madeleine T. King, Richard Norman, Daniel S. J. Costa, A. Simon Pickard, Dean A. Regier, Rosalie Viney & Stuart J. Peacock. (2019) The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30. MDM Policy & Practice 4:1, pages 238146831984253.
Crossref
Crossref
Madeleine T. King, Rosalie Viney, A. Simon Pickard, Donna Rowen, Neil K. Aaronson, John E. Brazier, David Cella, Daniel S. J. Costa, Peter M. Fayers, Georg Kemmler, Helen McTaggart-Cowen, Rebecca Mercieca-Bebber, Stuart Peacock, Deborah J. Street, Tracey A. Young & Richard Norman. (2017) Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30. PharmacoEconomics 36:2, pages 225-238.
Crossref
Crossref
Weidong Huang, Hongjuan Yu, Chaojie Liu, Guoxiang Liu, Qunhong Wu, Jin Zhou, Xin Zhang, Xiaowen Zhao, Linmei Shi & Xiaoxue Xu. (2017) Assessing Health-Related Quality of Life of Chinese Adults in Heilongjiang Using EQ-5D-3L. International Journal of Environmental Research and Public Health 14:3, pages 224.
Crossref
Crossref
M. T. King, D. S. J. Costa, N. K. Aaronson, J. E. Brazier, D. F. Cella, P. M. Fayers, P. Grimison, M. Janda, G. Kemmler, R. Norman, A. S. Pickard, D. Rowen, G. Velikova, T. A. Young & R. Viney. (2016) QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Quality of Life Research 25:3, pages 625-636.
Crossref
Crossref
Noémi V. Hevér, Márta Péntek, András Balló, László Gulácsi, Petra Baji, Valentin Brodszky, Miklós Damásdi, Zita Bognár, György Tóth, István Buzogány & Árpád Szántó. (2014) Health Related Quality of Life in Patients with Bladder Cancer: A Cross-Sectional Survey and Validation Study of the Hungarian Version of the Bladder Cancer Index. Pathology & Oncology Research 21:3, pages 619-627.
Crossref
Crossref
Scott D. Ramsey, Richard J. Willke, Henry Glick, Shelby D. Reed, Federico Augustovski, Bengt Jonsson, Andrew Briggs & Sean D. Sullivan. (2015) Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report. Value in Health 18:2, pages 161-172.
Crossref
Crossref
J. Diels, P. Hamberg, D. Ford, P. Wheatley Price, M. Spencer & R. N. Dass. (2014) Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients. Quality of Life Research 24:3, pages 591-598.
Crossref
Crossref